OTCShotCaller
08:13 AM
The historic results of this breakthrough in Immuno-Oncology with the Check Point Inhibitor Drug is gone vial as expected. The media is catching onto this very quickly after this CNN Interview!
lasvegassun.com/news/2022/j...
Moving forward I expect there should be several Big Pharmas or Private Investors more than willing to fund our IND for mRNA Cancer Vaccine treatment of pancreatic and colon cancer.
At this point it's a NO BRAINER!
8
OTCShotCaller
Bullish
07:58 AM
$RGBP
- Well folks it appears we've arrived! 100% PROOF Dr. Koos is on the right track with our Check-Point Inhibitor for treating Cancer!
Just out yesterday June 6, 2022, Oncologist Dr. Andrea Cercek at Memorial Sloan Kettering Cancer Center is interviewed on CNN regarding the results of a clinical trial on 14 patients with colorectal cancer treated with the Immunotherapy Drug Dostarlimab. All 14 patients had 100% disappearance of the rectal cancer within 24 weeks of treatment with little or no side effects.
youtube.com/watch?v=a0rbO3p...
Dostarlimab was developed by a Biotech by the name of Tesaro which was later bought by GlaxoSmithKline January 2019 for $5.1B. The results of the above study was published in The New England Journal of Medicine on June 5th that describes these historic results of all patents being cancer free after treatment.
beckersasc.com/gastroentero...
This is what I've mentioned here hundreds of times, i.e. we're entering into a Paradigm Shift in the Practice of Medicine.
News 
Market Data 
Discover 
AI
